Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Nuclear Medicine

Free Subscription 20.01.2025 2 Ann Nucl Med 4 Clin Nucl Med 1 Heart 2 J Neuroimaging 8 J Nucl Med 1 Neurol Genet 3 Neurology 2 Nucl Med Commun 3 Phys Med Biol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Nucl Med

1. ZHANG G, Shen J, Hu T, Zheng W, et al
   Utility of (18)F-FDG PET/CT metabolic parameters on post-transplant lymphoproliferative disorder diagnosis.
   Ann Nucl Med. 2025 Jan 18. doi: 10.1007/s12149-025-02016.
   PubMed         Abstract available
   
   
2. GUGLIELMO P, Buffi N, Porreca A, Setti L, et al
   Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review.
   Ann Nucl Med. 2025 Jan 15. doi: 10.1007/s12149-025-02015.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

3. KOORMA H, Jayanthi MR, Vengala S, Reddy AV, et al
   Incidentally Diagnosed Endolymphatic Sac Tumor on 68Ga-DOTA-TATE PET/CT in a Suspected Case of Pheochromocytoma.
   Clin Nucl Med. 2025 Jan 14. doi: 10.1097/RLU.0000000000005642.
   PubMed         Abstract available
   
   
4. CECCON GS, Werner JM, Ruge MI, Goldbrunner R, et al
   The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse.
   Clin Nucl Med. 2025 Jan 14. doi: 10.1097/RLU.0000000000005634.
   PubMed         Abstract available
   
   
5. WANG R, Li Y, Li Z, Wang J, et al
   Gastrin-Releasing Peptide Receptor Targeting PET/CT With 68Ga-NOTA-RM26 in the Assessment of Glioma and Combined Multiregional Biopsies.
   Clin Nucl Med. 2025 Jan 14. doi: 10.1097/RLU.0000000000005651.
   PubMed         Abstract available
   
   
6. NGAM PI, Anzai Y, Minoshima S
   Developmental Venous Anomaly: Its Impact on Brain Parenchymal Function as Revealed by FDG PET.
   Clin Nucl Med. 2025 Jan 14. doi: 10.1097/RLU.0000000000005654.
   PubMed         Abstract available
   
   

   
   Heart

7. HENRY JA, Xavier R, Selvaraj E, Burrage M, et al
   Exploring cardiovascular involvement in IgG4-related disease: a case series approach with cardiovascular magnetic resonance.
   Heart. 2024 Nov 7:heartjnl-2024-324785. doi: 10.1136/heartjnl-2024-324785.
   PubMed         Abstract available
   
   

   
   J Neuroimaging

8. JENSEN P, Ozenne B, Meden P, Feng L, et al
   Poststroke Translocator Protein Expression Dynamics and Correlations to Chronic Infarction: A ([123I])-CLINDE-SPECT Study.
   J Neuroimaging. 2025;35:e70002.
   PubMed         Abstract available
   
   
9. JEONG EH, Lee JY, Song YS
   Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia.
   J Neuroimaging. 2025;35:e70014.
   PubMed         Abstract available
   
   

   
   J Nucl Med

10. LANGEN KJ, Stoffels G, Filss CP, Kocher M, et al
    Borderline Findings in O-(2-[(18)F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice.
    J Nucl Med. 2025 Jan 16:jnumed.124.268768. doi: 10.2967/jnumed.124.268768.
    PubMed         Abstract available
    
    
11. GAO M, Daube-Witherspoon ME, Karp JS, Surti S, et al
    Total-Body PET System Designs with Axial and Transverse Gaps: A Study of Lesion Quantification and Detectability.
    J Nucl Med. 2025 Jan 16:jnumed.124.267769. doi: 10.2967/jnumed.124.267769.
    PubMed         Abstract available
    
    
12. PRASAD N, Harris E, DeFilippis EM, Sayer G, et al
    PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes.
    J Nucl Med. 2025 Jan 16:jnumed.124.268713. doi: 10.2967/jnumed.124.268713.
    PubMed         Abstract available
    
    
13. CERIANI L, Milan L, Pirosa MC, Martelli M, et al
    PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort.
    J Nucl Med. 2025 Jan 16:jnumed.124.268874. doi: 10.2967/jnumed.124.268874.
    PubMed         Abstract available
    
    
14. BARBRY F, Chevalier B, Beron A, Lion G, et al
    Redifferentiation of a RET-Fusion, Radioiodine-Refractory, Differentiated Thyroid Cancer with Selpercatinib: Flip-Flop Between [(18)F]FDG PET/CT and (131)I Posttreatment Scanning.
    J Nucl Med. 2025 Jan 16:jnumed.124.268539. doi: 10.2967/jnumed.124.268539.
    PubMed        
    
    
15. ENKE JS, Reitsam NG, Dintner S, Liesche-Starnecker F, et al
    Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical Therapy.
    J Nucl Med. 2025 Jan 16:jnumed.124.268513. doi: 10.2967/jnumed.124.268513.
    PubMed         Abstract available
    
    
16. BAILEY DL, Willowson KP, O'Keefe G, Goodman S, et al
    A Method for Validating PET and SPECT Cameras for Quantitative Clinical Imaging Trials Using Novel Radionuclides.
    J Nucl Med. 2025 Jan 16:jnumed.124.268578. doi: 10.2967/jnumed.124.268578.
    PubMed         Abstract available
    
    
17. RAMOS-TORRES KM, Conti S, Zhou YP, Tiss A, et al
    Imaging Demyelinated Axons After Spinal Cord Injuries with PET Tracer [(18)F]3F4AP.
    J Nucl Med. 2025 Jan 16:jnumed.124.268242. doi: 10.2967/jnumed.124.268242.
    PubMed         Abstract available
    
    

    
    Neurol Genet

18. YAMAMOTO Y, Takahata K, Seki M, Okusa S, et al
    SLC9A6-Linked Parkinson Syndrome in Female Heterozygotes Is Associated With PET-Detectable Tau Pathology.
    Neurol Genet. 2025;11:e200235.
    PubMed         Abstract available
    
    

    
    Neurology

19. BORNHORST JA, Lundgreen CS, Weigand SD, Figdore DJ, et al
    Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations.
    Neurology. 2025;104:e210287.
    PubMed         Abstract available
    
    
20. JOUTSA J, Rinne JO, Niemi KJ, Karrasch M, et al
    Progression of Amyloid Accumulation in Late Adulthood Among People With Childhood-Onset Epilepsy.
    Neurology. 2025;104:e210303.
    PubMed         Abstract available
    
    
21. GARCIA-ESPERON C, Berry-Noronha A, Di Bartolo A, Green DS, et al
    Arterial Input Function Dispersal on Acute Brain CT Perfusion Scan in Patients With Acute Stroke and an Intracardiac Thrombus.
    Neurology. 2025;104:e210256.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

22. KOTE R, Ravina M, Goyal H, Mohanty D, et al
    Role of textural and radiomic analysis parameters in predicting histopathological parameters of the tumor in breast cancer patients.
    Nucl Med Commun. 2024;45:835-847.
    PubMed         Abstract available
    
    
23. ULRICH M, Lehnick D, Strobel K, Grunig H, et al
    Quantitative bone single photon emission computed tomography/computed tomography in symptomatic and asymptomatic foot and ankle osteoarthritis.
    Nucl Med Commun. 2024;45:848-857.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

24. WEI Q, Li D, Huang X, Wei L, et al
    Crystal-level timing calibration using cascaded photons of(60)Co point source for long axial animal PET system.
    Phys Med Biol. 2025 Jan 17. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    
25. LEQUERTIER V, Testa E, Maxim V
    CoReSi: a GPU-based software for Compton camera reconstruction and simulation in collimator-free SPECT.
    Phys Med Biol. 2025 Jan 15. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    
26. TAKYU S, Tashima H, Takahashi M, Yoshida E, et al
    A whole gamma imaging prototype for higher quantitative imaging of(89)Zr-labeled antibodies in a tumor mouse model.
    Phys Med Biol. 2025;70.
    PubMed         Abstract available
    
    

    
    PLoS One

27. NOGUEIRA SA, Luz FAB, Camargo TFO, Oliveira JCS, et al
    Artificial intelligence applied in identifying left ventricular walls in myocardial perfusion scintigraphy images: Pilot study.
    PLoS One. 2025;20:e0312257.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.